Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Portia G. Velasquez"'
Autor:
Chantale Bernatchez, Rodabe N. Amaria, Patrick Hwu, Rameen Beroukhim, Carlos A. Torres-Cabala, Laszlo G. Radvanyi, Jennifer A. Wargo, Janice N. Cormier, Richard Royal, Anthony Lucci, Jeffrey E. Gershenwald, Jeffrey E. Lee, Merrick I. Ross, Suzanne Cain, Michael K. Wong, Hussein Tawbi, Isabella C. Glitza, Adi Diab, Michael A. Davies, Sapna P. Patel, Wen-Jen Hwu, Portia G. Velasquez, Chantell M. Farinas, Carol Vaughn, Destiny Joy Carpio, Vruti Patel, Rahmatu Mansaray, Seth Wardell, Christopher L. Toth, Audrey M. Gonzalez, Renjith Ramachandran, René J. Tavera, Shawne T. Thorsen, Esteban Flores, Arely Wahl, Ankit Bhatta, Donastas Sakellariou-Thompson, Young Uk Kim, Scott E. Woodman, Jason Roszik, Orenthial J. Fulbright, Tatiana Karpinets, Caitlin Creasy, Yuzhong Jeff Meng, Kenneth R. Hess, Cara Haymaker, Marie-Andrée Forget
Purpose: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) has consistently demonstrated clinical efficacy in metastatic melanoma. Recent widespread use of checkpoint blockade has shifted the treatment landscape, raising question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e3bef375d825fda45fd3b58565f392d
https://doi.org/10.1158/1078-0432.c.6527361.v1
https://doi.org/10.1158/1078-0432.c.6527361.v1
Autor:
Chantale Bernatchez, Rodabe N. Amaria, Patrick Hwu, Rameen Beroukhim, Carlos A. Torres-Cabala, Laszlo G. Radvanyi, Jennifer A. Wargo, Janice N. Cormier, Richard Royal, Anthony Lucci, Jeffrey E. Gershenwald, Jeffrey E. Lee, Merrick I. Ross, Suzanne Cain, Michael K. Wong, Hussein Tawbi, Isabella C. Glitza, Adi Diab, Michael A. Davies, Sapna P. Patel, Wen-Jen Hwu, Portia G. Velasquez, Chantell M. Farinas, Carol Vaughn, Destiny Joy Carpio, Vruti Patel, Rahmatu Mansaray, Seth Wardell, Christopher L. Toth, Audrey M. Gonzalez, Renjith Ramachandran, René J. Tavera, Shawne T. Thorsen, Esteban Flores, Arely Wahl, Ankit Bhatta, Donastas Sakellariou-Thompson, Young Uk Kim, Scott E. Woodman, Jason Roszik, Orenthial J. Fulbright, Tatiana Karpinets, Caitlin Creasy, Yuzhong Jeff Meng, Kenneth R. Hess, Cara Haymaker, Marie-Andrée Forget
Supplementary figures and tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6b63fa11af3a2699661a106b5fc2f5
https://doi.org/10.1158/1078-0432.22469814
https://doi.org/10.1158/1078-0432.22469814
Autor:
Carlos A. Torres-Cabala, Jeffrey E. Gershenwald, Jason Roszik, Vruti Patel, Wen-Jen Hwu, Anthony Lucci, M. I. Ross, Arely Wahl, Orenthial J. Fulbright, Yuzhong Jeff Meng, Christopher Toth, Tatiana Karpinets, Cara Haymaker, Chantell M. Farinas, Sapna Pradyuman Patel, Adi Diab, Caitlin Creasy, Patrick Hwu, Renjith Ramachandran, Jeffrey E. Lee, Isabella C. Glitza, Ankit Bhatta, Destiny Joy Carpio, Rodabe N. Amaria, Esteban Flores, Suzanne Cain, Michael K. Wong, Laszlo Radvanyi, Rameen Beroukhim, Portia G. Velasquez, Hussein Abdul-Hassan Tawbi, Chantale Bernatchez, Carol Vaughn, Shawne T. Thorsen, Marie Andrée Forget, Michael A. Davies, Young Uk Kim, Seth Wardell, Janice N. Cormier, Scott E. Woodman, Jennifer A. Wargo, Rahmatu Mansaray, Richard E. Royal, Rene J. Tavera, Audrey M. Gonzalez, Kenneth R. Hess, Donastas Sakellariou-Thompson
Purpose: Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TIL) has consistently demonstrated clinical efficacy in metastatic melanoma. Recent widespread use of checkpoint blockade has shifted the treatment landscape, raising question
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd2241bcc6c3505a54b6f6cfb5977d7
https://europepmc.org/articles/PMC6139043/
https://europepmc.org/articles/PMC6139043/
Autor:
Portia G. Velasquez, Isabella C. Glitza, Michael A. Davies, Cassian Yee, Rodabe N. Amaria, Sapna Pradyuman Patel, Adi Diab, Agop Y. Bedikian, Wen-Jen Hwu, Chantale Bernatchez, Carol Vaughn, Nicholas E. Papadopoulos, Scott E. Woodman, Laszlo Radvanyi, Patrick Hwu, Kevin B. Kim, Roland L. Bassett
Publikováno v:
Journal of Clinical Oncology. 32:9079-9079
9079 Background: In this report we describe the association of specific patient attributes, such as mutation status, prior treatment with checkpoint blockade, and location of primary tumor with tre...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f622a325df80aeb1faa2c3bfc94c6e65
https://doi.org/10.1200/jco.2014.32.15_suppl.9079
https://doi.org/10.1200/jco.2014.32.15_suppl.9079
